Journal Guides8 min readUpdated Apr 14, 2026

Is Cell a Good Journal? Impact Factor, Comparison, and Fit Verdict

Cell journal fit verdict with key metrics, comparison to Nature and Science, and practical submit-or-skip guidance for authors.

Research Scientist, Neuroscience & Cell Biology

Author context

Works across neuroscience and cell biology, with direct expertise in preparing manuscripts for PNAS, Nature Neuroscience, Neuron, eLife, and Nature Communications.

Journal fit

See whether this paper looks realistic for Cell.

Run the Free Readiness Scan with Cell as your target journal and see whether this paper looks like a realistic submission.

Check my manuscript fitAnthropic Privacy Partner. Zero-retention manuscript processing.See sample report
Journal context

Cell at a glance

Key metrics to place the journal before deciding whether it fits your manuscript and career goals.

Full journal profile
Impact factor42.5Clarivate JCR
Acceptance rate<8%Overall selectivity
Time to decision~14 days to first decisionFirst decision

What makes this journal worth targeting

  • IF 42.5 puts Cell in a visible tier — citations from papers here carry real weight.
  • Scope specificity matters more than impact factor for most manuscript decisions.
  • Acceptance rate of ~<8% means fit determines most outcomes.

When to look elsewhere

  • When your paper sits at the edge of the journal's stated scope — borderline fit rarely improves after submission.
  • If timeline matters: Cell takes ~~14 days to first decision. A faster-turnaround journal may suit a grant or job deadline better.
  • If open access is required by your funder, verify the journal's OA agreements before submitting.
Quick verdict

How to read Cell as a target

This page should help you decide whether Cell belongs on the shortlist, not just whether it sounds impressive.

Question
Quick read
Best for
Cell publishes findings of unusual significance in any area of experimental biology. Where Nature emphasizes.
Editors prioritize
Mechanistic completeness
Think twice if
Submitting a 'first observation' without mechanism
Typical article types
Article, Resource, Short Article

Cell (IF 42.5, Cell Press) publishes mechanistically complete biology where the figures carry the argument from first panel to last. If you cannot imagine your paper working as a visual narrative across 7-10 figures, each one advancing the mechanistic logic, it probably belongs somewhere else.

Key Metrics

Metric
Value
Impact Factor (2024 JCR)
42.5
Publisher
Cell Press (Elsevier)
Acceptance Rate
~7-10%
Desk Rejection Rate
50-70%
Median Time to Acceptance
~280 days
Typical Figure Count
7-10 main figures
Open Access
Hybrid (subscription with OA option)
Quartile
Q1 (Cell Biology; Biochemistry & Molecular Biology)

What Makes Cell Different

Cell's editorial identity comes down to two words: mechanism and completeness.

Many journals accept strong observations. Cell does not. The paper has to explain how a biological process works at a level that closes the loop. That means orthogonal evidence, multiple model systems where appropriate, and a story arc that feels finished rather than promising.

The visual narrative test is real. Cell papers are figure-heavy for a reason. The editors and reviewers expect that a reader could follow the core argument by looking at the figures alone, without reading the text. If your manuscript depends on paragraphs of interpretation to connect one experiment to the next, the figure structure is not Cell-ready.

The 280-day median time to acceptance reflects what happens after the desk screen. Revisions at Cell are negotiated, often involving additional experiments and sometimes entirely new figure panels. This is not a fast-turnaround journal. Authors who need speed should plan accordingly.

How Cell Compares

Journal
IF (2024)
Best For
Key Difference from Cell
Nature
48.5
Broad science, all fields
Broader scope, less figure-dependent storytelling
Science
45.8
Broad science, all fields
Shorter format, faster turnaround
Nature Methods
32.1
New methods and technologies
Methods-first rather than mechanism-first
Molecular Cell
16.6
Molecular mechanisms
Narrower scope, less breadth required

Cell vs Nature: Nature takes broader science and does not require the same degree of figure-driven mechanistic closure. A paper that works as a compelling narrative across disciplines often fits Nature better. A paper that is deep, mechanistically closed, and primarily biological fits Cell.

Cell vs Science: Science runs shorter manuscripts with faster editorial cycles. If the story can be told tightly in fewer figures, Science may be the better match. Cell rewards the longer, more complete mechanistic treatment.

Cell vs Nature Methods: Nature Methods publishes technology and methodology that enables new biology. If the contribution is the tool rather than the biological insight it produces, Nature Methods is the more honest target.

Cell vs Molecular Cell: Molecular Cell (IF 16.6) publishes strong molecular biology that does not need to reach as broadly. If the paper is excellent but the audience is one molecular biology community rather than biology at large, Molecular Cell is often the right call.

The Editorial Distinction

Cell's in-house professional editors are biologists themselves, not generalists managing a broad portfolio. They read the figures before they read the text, and they are looking for one thing above all: does this paper reveal how something in biology actually works, and does the evidence already close the case?

The negotiated revision process means that a revision letter from Cell is not a checklist of minor fixes. It is a conversation about what additional experiments would make the mechanism airtight. Authors should expect to spend months on revision, sometimes adding two or three new figure panels.

Submit If

  • The mechanism is already closed and the figures carry the argument without heavy text explanation
  • You have 7-10 figures worth of convergent evidence from multiple approaches
  • The biological consequence is visible from figure one, not buried in the discussion
  • The story is broad enough that biologists outside your subfield would care
  • You can absorb a 280-day timeline including a potentially demanding revision

Journal fit

See whether this paper looks realistic for Cell.

Run the scan with Cell as the target. Get a manuscript-specific fit signal before you commit.

Check my manuscript fitAnthropic Privacy Partner. Zero-retention manuscript processing.See sample report

Think Twice If

  • The paper is a strong first observation but the mechanism is still open
  • The real audience is one specialist community, even if the work is excellent
  • The central claim depends on one missing causal or in vivo bridge experiment
  • You need the result published within six months
  • The paper mainly needs the Cell name to feel broader than it actually is

Frequently Asked Questions

Is Cell a good journal?

Yes. Cell is one of the three most prestigious scientific journals alongside Nature and Science, with a 2024 impact factor of 42.5. Published by Cell Press, it is the leading venue for mechanistically complete biology where figures carry the entire argument.

What is Cell's acceptance rate?

Cell accepts roughly 7-10% of submissions. Desk rejection runs 50-70%. The median time from submission to acceptance is approximately 280 days, reflecting the depth of review and revision that Cell demands.

How many figures does a typical Cell paper have?

A typical Cell paper includes 7-10 main figures, often with extensive supplementary material. This figure count reflects the journal's expectation that the visual narrative alone should carry the core argument without heavy reliance on text.

What is Cell's impact factor?

Cell has a 2024 JCR impact factor of 42.5. It is ranked Q1 in both Biochemistry/Molecular Biology and Cell Biology, placing it among the highest-impact journals in all of science.

What Pre-Submission Reviews Reveal About Cell Submissions

In our pre-submission review work with manuscripts targeting Cell, three patterns generate the most consistent desk rejections among the papers we analyze.

Incomplete mechanistic closure. Cell's author guidelines state that manuscripts must present "a full story" rather than observations requiring future validation. We see manuscripts with strong initial observations and compelling model figures, but with one causal bridge experiment missing: typically the in vivo confirmation or the genetic rescue that closes the loop. Editors identify these gaps at the screening stage, not after peer review, and desk-reject rather than ask authors to do additional experiments before review.

Figure narratives that depend on paragraph-level text to connect experiments. Cell's in-house editors read figures before reading text. The journal guidelines explicitly require that each figure advance the mechanistic argument and that the visual sequence tell the story without heavy textual interpretation. SciRev author reports flag "figure logic" as a recurring editorial comment. We observe that manuscripts where the connection between figures 3 and 4 only becomes clear after reading two paragraphs of the results section are routinely returned without review.

Breadth claims that are asserted rather than demonstrated. Cell papers must matter broadly across biology, not just within one mechanistic community. We find manuscripts that position a specific molecular finding as broadly significant, but where every experiment is conducted in one cell line, one organism, or one disease context. The journal's scope statement emphasizes findings that "provide mechanistic insight into biological processes relevant to a broad scientific audience." Editors screen for whether the breadth of significance is actually in the data or only in the framing.

SciRev author-reported data confirms Cell's approximately 280-day median time to acceptance, reflecting deep revision demands. A Cell mechanistic closure and figure logic check can assess whether the loop is actually closed before you invest that timeline.

Bottom Line

Cell is the right journal when the mechanism is already closed, the figures tell the story on their own, and the biology matters broadly. It is the wrong journal when the paper is still promising rather than finished, or when the flagship label is doing more work than the data.

Before submitting, a Cell submission readiness check can flag gaps in mechanistic completeness, figure-narrative logic, and breadth framing before editors do.

Frequently asked questions

Yes. Cell is one of the three most prestigious scientific journals alongside Nature and Science, with a 2024 impact factor of 42.5. Published by Cell Press, it is the leading venue for mechanistically complete biology where figures carry the entire argument.

Cell accepts roughly 7-10% of submissions. Desk rejection runs 50-70%. The median time from submission to acceptance is approximately 280 days, reflecting the depth of review and revision that Cell demands.

A typical Cell paper includes 7-10 main figures, often with extensive supplementary material. This figure count reflects the journal's expectation that the visual narrative alone should carry the core argument without heavy reliance on text.

Cell has a 2024 JCR impact factor of 42.5. It is ranked Q1 in both Biochemistry/Molecular Biology and Cell Biology, placing it among the highest-impact journals in all of science.

References

Sources

  1. 1. Cell journal homepage, Cell Press / Elsevier.
  2. 2. Cell information for authors, Cell Press.
  3. 3. Clarivate Journal Citation Reports (released June 2025).

Final step

See whether this paper fits Cell.

Run the Free Readiness Scan with Cell as your target journal and get a manuscript-specific fit signal before you commit.

Anthropic Privacy Partner. Zero-retention manuscript processing.

Internal navigation

Where to go next

Check my manuscript fit